Clinical Trial

Bovine Reinforcement in Stomach, Colorectal and Lung Operation

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary purpose of this prospective, randomized multicenter center study is to evaluate and compare the outcomes of stomach,colorectal and lung anastomoses reinforced with a bioabsorbable staple line reinforcement material compared with standard non-reinforced techniques with respect to the incidence of postoperative hemorrage rate, anastomotic leakage, if applicable.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-05.
Trial Details
NCT Number NCT06968221
Lead Sponsor Shanghai Cingularbio Co. Ltd
Collaborators: RenJi Hospital
Conditions Rectal Cancer Stage III, Lung Cancer Stage III
Enrollment 172 participants
Start Date 2025-05-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-15